NRG HN007

Primary Category:

Treatment Protocols

Disease Category:

Head and Neck, Head and Neck Metastatic

Status:

Temporarily Closed

An Open-Label, Phase III Study of Platinum-Gemcitabine with or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Eligible for screening study DCP 001

HN007 is temporarily closed to accrual effective June 14, 2021.

NCT#04458909